Psyence BiomedicalPBMWW Preferred / convertible 13F holders, Q1 2024 (March 31) 30 holders
1 famous investor
$0.08 avg. 13F price*
At the end of Q1 2024 , 30 institutions reported holding Psyence Biomedical Ltd. (PBMWW) in their 13F filings. The largest holders were EHP Funds Inc. ($86K), Cantor Fitzgerald, L. P. ($60K) and Polar Asset Management Partners Inc. ($51K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
Company Psyence Biomedical Ltd.
CUSIP 74449F118
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q1 2024 Institutions Total Value New Positions 30 $495K Exits 0 $0
Ownership 30 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ EHP Funds Inc. — New 1,232,748 $86K Cantor Fitzgerald, L. P. — New 468,500 $60K Polar Asset Management Partners Inc. — New 733,000 $51K MMCAP International Inc. SPC — New 600,000 $42K Calamos Advisors LLC — New 500,000 $36K Saba Capital Management, L.P. — New 297,847 $21K Periscope Capital Inc. — New 300,000 $21K Aristeia Capital, L.L.C. — New 272,857 $20K Clear Street Derivatives LLC — — 277,919 $19K Context Capital Management, LLC — New 234,200 $16K Anson Funds Management LP — New 12,500 $14K LMR Partners LLP — New 200,000 $14K Walleye Capital LLC — New 198,296 $14K Clear Street LLC — New 180,276 $13K D. E. Shaw & Co. — New 175,352 $13K Shaolin Capital Management LLC — New 175,000 $12K TENOR CAPITAL MANAGEMENT Co., L.P. — New 150,000 $11K Wolverine Asset Management LLC — New 134,917 $9K Cowen and Company, LLC — New 130,287 $9K Westchester Capital Management, LLC — New 92,073 $7K Yakira Capital Management, Inc. — New 76,843 $5K Mizuho Securities USA LLC — New 89,325 $4K Mint Tower Capital Management B.V. — New 50,000 $4K Flow State Investments, L.P. — New 55,000 $4K Whitebox Advisors LLC — New 50,000 $4K Walleye Trading LLC — New 24,354 $2K Schonfeld Strategic Advisors LLC — New 24,300 $2K SkyView Investment Advisors, LLC — New 17,500 $1K Ancora Advisors LLC — New 5,000 $350 UBS Group AG — New 73 $5
"% of holder's portfolio" is PBMWW's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.